Effects of Recombinant Human Leukemia Inhibitor on the Preimplantation Mouse Embryo Development in Vitro

Guoyun Wang,Xiaohui Deng,Huiqin Zhang,Hongling Yu,Sen Jiang
DOI: https://doi.org/10.3760/j.issn:0529-567x.2002.02.003
2002-01-01
Abstract:OBJECTIVE:To assess the effect of recombinant human leukemia inhibitory factor (rhLIF) on mouse embryo development in vitro.METHODS:Mice were randomly divided to three groups, one in vivo control (group I) and two in vitro (group II and III). Mice were sacrificed at 116 - 120 hours (group I) and 44 - 48 hours (group II and III) subsequent human chorionic gonadotropin (hCG) injection. Two-cell embryos (group II and III) and blastocysts (group I) were obtained. Embryos in group II were cocultured with human tubal fluid (HTF) + 10% human serum and in group III with HTF + 10% human serum + rhLIF (1 000 U/ml). The number of embryo in different stage was recorded and compared.RESULTS:Embryo in four, eight-cell and morula was noted in group II and III, 87.7% versus 91.2% and 75.0% versus 85.4% respectively. There was no significant difference. However, further embryo development to the blastocyst, expanded blastocyst, and hatching blastocyst in group II (48.1%, 32.1% and 18.4%) was lower than that in group III (82.3%, 59.7% and 36.3%). There was no difference between blastocyst in group I and group III (86.0% vs 82.3%).CONCLUSION:RhLIF does not provide obvious stimulation in early mouse embryo, however, rhLIF can promote the growth, differentiation, and hatching of preimplantion blastocyst.
What problem does this paper attempt to address?